{"id":300353,"date":"2025-07-10T19:47:44","date_gmt":"2025-07-10T19:47:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/gpc-stock-2\/"},"modified":"2025-07-10T19:47:44","modified_gmt":"2025-07-10T19:47:44","slug":"gpc-stock","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/","title":{"rendered":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":45,"featured_media":178545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[47,39,45],"class_list":["post-300353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-beginner","tag-platform","tag-stock"],"acf":{"h1":"Pocket Option, GPC hisselerini analiz ediyor","h1_source":{"label":"H1","type":"text","formatted_value":"Pocket Option, GPC hisselerini analiz ediyor"},"description":"Pocket Option uzmanlar\u0131ndan GPC hissesi hakk\u0131nda detayl\u0131 bilgiler ke\u015ffedin - teknik analiz, b\u00fcy\u00fcme potansiyeli ve etkili yat\u0131r\u0131m stratejileri. Bug\u00fcn Vietnaml\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bilgiler!","description_source":{"label":"Description","type":"textarea","formatted_value":"Pocket Option uzmanlar\u0131ndan GPC hissesi hakk\u0131nda detayl\u0131 bilgiler ke\u015ffedin - teknik analiz, b\u00fcy\u00fcme potansiyeli ve etkili yat\u0131r\u0131m stratejileri. Bug\u00fcn Vietnaml\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bilgiler!"},"intro":"Bu makale, Vietnam pazar\u0131ndaki dikkat \u00e7ekici menkul k\u0131ymetlerden biri olan Imexpharm Pharmaceutical Joint Stock Company'nin GPC hissesi hakk\u0131nda derinlemesine bir bak\u0131\u015f sunmaktad\u0131r. Teknik analiz, temel de\u011ferlendirme ve makroekonomik fakt\u00f6rlerin dikkate al\u0131nmas\u0131 yoluyla, makale yat\u0131r\u0131mc\u0131lara 2025 piyasas\u0131 ba\u011flam\u0131nda ak\u0131ll\u0131 kararlar vermelerinde yard\u0131mc\u0131 olmaktad\u0131r.","intro_source":{"label":"Intro","type":"text","formatted_value":"Bu makale, Vietnam pazar\u0131ndaki dikkat \u00e7ekici menkul k\u0131ymetlerden biri olan Imexpharm Pharmaceutical Joint Stock Company'nin GPC hissesi hakk\u0131nda derinlemesine bir bak\u0131\u015f sunmaktad\u0131r. Teknik analiz, temel de\u011ferlendirme ve makroekonomik fakt\u00f6rlerin dikkate al\u0131nmas\u0131 yoluyla, makale yat\u0131r\u0131mc\u0131lara 2025 piyasas\u0131 ba\u011flam\u0131nda ak\u0131ll\u0131 kararlar vermelerinde yard\u0131mc\u0131 olmaktad\u0131r."},"body_html":"<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>GPC Hisse Senedi ve Vietnam'\u0131n \u0130la\u00e7 Sekt\u00f6r\u00fcndeki Konumu \u00dczerine Genel Bak\u0131\u015f<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>GPC hisse senedi, 1977 y\u0131l\u0131nda kurulan Vietnam'\u0131n \u00f6nde gelen ila\u00e7 i\u015fletmelerinden biri olan Imexpharm Pharmaceutical Joint Stock Company'ye aittir. 40 y\u0131l\u0131 a\u015fk\u0131n bir geli\u015fim s\u00fcreciyle Imexpharm, yerel ve b\u00f6lgesel ila\u00e7 pazarlar\u0131nda sa\u011flam bir konum olu\u015fturmu\u015ftur. \u015eirket, \u00f6zellikle antibiyotikler ve fonksiyonel g\u0131dalar olmak \u00fczere y\u00fcksek kaliteli ila\u00e7 \u00fcr\u00fcnlerinin \u00fcretimi ve ticareti konusunda uzmanla\u015fm\u0131\u015ft\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Vietnam'\u0131n h\u0131zla geli\u015fen ila\u00e7 sekt\u00f6r\u00fc ba\u011flam\u0131nda, GPC hisse senedi giderek daha fazla yat\u0131r\u0131mc\u0131 ilgisini \u00e7ekmektedir. Vietnam ila\u00e7 pazar\u0131n\u0131n, 2023-2028 d\u00f6neminde y\u0131ll\u0131k bile\u015fik b\u00fcy\u00fcme oran\u0131 (CAGR) olarak yakla\u015f\u0131k %10-12 oran\u0131nda b\u00fcy\u00fcmesi \u00f6ng\u00f6r\u00fclmektedir, bu da k\u00fcresel ortalaman\u0131n \u00fczerindedir. Bu, Imexpharm dahil olmak \u00fczere yerli ila\u00e7 \u015firketlerinin geli\u015fim beklentileri i\u00e7in \u00f6nemli bir itici g\u00fc\u00e7t\u00fcr.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Rekabet\u00e7i konum a\u00e7\u0131s\u0131ndan, Imexpharm, AB-GMP ve WHO-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan y\u00fcksek kaliteli \u00fcr\u00fcn hatlar\u0131na odaklanarak s\u00fcrd\u00fcr\u00fclebilir bir geli\u015fim stratejisi ile \u00f6ne \u00e7\u0131kmaktad\u0131r. Bu, \u00f6zellikle Vietnaml\u0131 t\u00fcketicilerin ila\u00e7 kalitesine giderek daha fazla \u00f6nem vermesi ve yerli \u00fcretilen ila\u00e7lar\u0131n kullan\u0131m trendinin artmas\u0131yla \u00f6nemli bir rekabet avantaj\u0131d\u0131r. 2024 y\u0131l\u0131nda Imexpharm, \u00fcretim kapasitesini art\u0131ran ve \u00fcr\u00fcn portf\u00f6y\u00fcn\u00fc geni\u015fleten y\u00fcksek teknoloji bir antibiyotik \u00fcretim tesisi a\u00e7m\u0131\u015ft\u0131r.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>G\u00f6sterge<\/th><th>2022<\/th><th>2023<\/th><th>2024<\/th><th>2025 Tahmin<\/th><\/tr><\/thead><tbody><tr><td>Gelir (milyar VND)<\/td><td>1,480<\/td><td>1,650<\/td><td>1,842<\/td><td>2,100<\/td><\/tr><tr><td>Net Kar (milyar VND)<\/td><td>248<\/td><td>290<\/td><td>325<\/td><td>380<\/td><\/tr><tr><td>EPS (VND)<\/td><td>3,750<\/td><td>4,200<\/td><td>4,650<\/td><td>5,400<\/td><\/tr><tr><td>ROE (%)<\/td><td>14.2<\/td><td>15.3<\/td><td>16.1<\/td><td>17.2<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>GPC Hisse Senedinin Temel ve Finansal Analizi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Temel analiz, GPC hisse senedinin potansiyelini de\u011ferlendirirken \u00f6nemli bir ad\u0131md\u0131r. Imexpharm'\u0131n son y\u0131llardaki i\u015f sonu\u00e7lar\u0131 istikrarl\u0131 bir b\u00fcy\u00fcme g\u00f6stermektedir. 2024 y\u0131l\u0131nda \u015firket, 2023'e g\u00f6re %11.6 art\u0131\u015fla 1,842 milyar VND gelir elde etti. Net kar, bir \u00f6nceki y\u0131la g\u00f6re %12.1 art\u0131\u015fla 325 milyar VND'ye ula\u015ft\u0131. Bu, hala bir\u00e7ok zorlukla kar\u015f\u0131 kar\u015f\u0131ya olan bir pazarda etkileyici bir b\u00fcy\u00fcmedir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Imexpharm'\u0131n finansal g\u00f6stergeleri de olduk\u00e7a olumlu. Br\u00fct kar marj\u0131, sekt\u00f6r ortalamas\u0131n\u0131n \u00fczerinde, %38-40 seviyesinde korunmaktad\u0131r. ROE (\u00d6zsermaye Getirisi) 2024 y\u0131l\u0131nda %16.1'e ula\u015farak, 2023'teki %15.3'ten y\u00fckselmi\u015ftir. Mevcut F\/K oran\u0131 yakla\u015f\u0131k 12-13 kat civar\u0131ndad\u0131r, bu da ila\u00e7 sekt\u00f6r\u00fc ortalamas\u0131 olan yakla\u015f\u0131k 15-16 kat\u0131n alt\u0131nda olup, hissenin fiyat de\u011ferleme potansiyelini g\u00f6stermektedir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>De\u011ferleme Metrikleri Analizi<\/h3><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>G\u00f6sterge<\/th><th>GPC<\/th><th>Sekt\u00f6r Ortalamas\u0131<\/th><th>De\u011ferlendirme<\/th><\/tr><\/thead><tbody><tr><td>F\/K<\/td><td>12.5<\/td><td>15.8<\/td><td>Cazip<\/td><\/tr><tr><td>P\/B<\/td><td>1.98<\/td><td>2.25<\/td><td>Makul<\/td><\/tr><tr><td>EV\/EBITDA<\/td><td>8.2<\/td><td>9.5<\/td><td>Cazip<\/td><\/tr><tr><td>Temett\u00fc Verimi (%)<\/td><td>3.5<\/td><td>2.8<\/td><td>\u0130yi<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Finansal durum a\u00e7\u0131s\u0131ndan, Imexpharm d\u00fc\u015f\u00fck bor\u00e7-\u00f6zsermaye oran\u0131 (yakla\u015f\u0131k 0.3 kat) ile sa\u011fl\u0131kl\u0131 bir sermaye yap\u0131s\u0131na sahiptir. \u015eirket, toplam varl\u0131klar\u0131n yakla\u015f\u0131k %15'ini olu\u015fturan bol miktarda nakde sahiptir, bu da i\u015fin geni\u015fleme projelerini ve yeni \u00fcr\u00fcnlerin ara\u015ft\u0131rma ve geli\u015ftirmesini finanse etmek i\u00e7in yeterli kaynaklara sahip olmas\u0131n\u0131 sa\u011flar. \u00d6zellikle, faiz oranlar\u0131n\u0131n d\u00fc\u015ft\u00fc\u011f\u00fc mevcut ba\u011flamda, Imexpharm'\u0131n d\u00fc\u015f\u00fck borcu \u00f6nemli bir avantajd\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Dikkate de\u011fer bir di\u011fer nokta ise \u015firketin temett\u00fc politikas\u0131d\u0131r. Imexpharm, hissedarlara kar payla\u015f\u0131m taahh\u00fcd\u00fcn\u00fc g\u00f6stererek, nakit ve hisse olarak yakla\u015f\u0131k %15-20 oran\u0131nda d\u00fczenli temett\u00fc \u00f6demeleri yapmaktad\u0131r. Mevcut fiyatla, GPC hisse senedinin temett\u00fc verimi, banka mevduat faiz oranlar\u0131n\u0131n ve sekt\u00f6r ortalamas\u0131n\u0131n \u00fczerinde, yakla\u015f\u0131k %3.5'tir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>GPC Hisse Senedinin Teknik Analizi ve Ticaret E\u011filimleri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Teknik analiz, yat\u0131r\u0131mc\u0131lar i\u00e7in fiyat e\u011filimleri ve ideal giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 hakk\u0131nda de\u011ferli bilgiler sa\u011flar. Teknik grafiklere g\u00f6re, GPC hisse senedi 2024'\u00fcn ilk alt\u0131 ay\u0131nda birikim a\u015famas\u0131ndan ge\u00e7ti ve 2024'\u00fcn \u00fc\u00e7\u00fcnc\u00fc \u00e7eyre\u011finden itibaren bir y\u00fckseli\u015f trendine ba\u015flad\u0131. \u015eu anda, hisse senedi MA50 (50 g\u00fcnl\u00fck hareketli ortalama) ve MA200 (200 g\u00fcnl\u00fck hareketli ortalama) \u00fczerinde i\u015flem g\u00f6rmekte olup, orta ve uzun vadeli yukar\u0131 y\u00f6nl\u00fc trendleri do\u011frulamaktad\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>RSI (G\u00f6receli G\u00fc\u00e7 Endeksi) gibi teknik g\u00f6stergeler 65 seviyesinde olup, hissenin hen\u00fcz a\u015f\u0131r\u0131 al\u0131m b\u00f6lgesinde olmad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir. MACD de sinyal \u00e7izgisinin \u00fczerinde pozitif momentum ile bulunmaktad\u0131r. Son 20 seansta ortalama i\u015flem hacmi, \u00f6nceki 20 seansa g\u00f6re %30 artarak yat\u0131r\u0131mc\u0131 ilgisinin artt\u0131\u011f\u0131n\u0131 yans\u0131tmaktad\u0131r.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Teknik G\u00f6sterge<\/th><th>Mevcut De\u011fer<\/th><th>Sinyal<\/th><\/tr><\/thead><tbody><tr><td>RSI (14)<\/td><td>65<\/td><td>Pozitif<\/td><\/tr><tr><td>MACD (12,26,9)<\/td><td>+2.15<\/td><td>Al<\/td><\/tr><tr><td>Bollinger Bantlar\u0131<\/td><td>\u00dcst banda yak\u0131n i\u015flem g\u00f6r\u00fcyor<\/td><td>Pozitif<\/td><\/tr><tr><td>Stokastik<\/td><td>82<\/td><td>A\u015f\u0131r\u0131 al\u0131m b\u00f6lgesine yak\u0131n<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Diren\u00e7 ve destek seviyeleri a\u00e7\u0131s\u0131ndan, GPC hisse senedi \u015fu anda 65,000 VND fiyat seviyesinde, ticaret tarihindeki en y\u00fcksek zirveye kar\u015f\u0131l\u0131k gelen g\u00fc\u00e7l\u00fc bir dirence sahiptir. \u00d6nemli destek seviyeleri 58,000 VND (MA50) ve 52,000 VND (MA200) seviyelerindedir. Uygun bir ticaret stratejisi, bu destek seviyelerinde al\u0131mlar\u0131 biriktirmek ve diren\u00e7 b\u00f6lgelerine yakla\u015f\u0131ld\u0131\u011f\u0131nda k\u0131smi kar almay\u0131 d\u00fc\u015f\u00fcnmektir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option'daki analistlere g\u00f6re, mevcut momentumla, GPC hisse senedinin 2025'in ikinci \u00e7eyre\u011finde 65,000 VND diren\u00e7 seviyesini a\u015fmas\u0131 muhtemeldir, \u00f6zellikle 2025'in ilk \u00e7eyre\u011fi i\u015f sonu\u00e7lar\u0131 olumlu olmaya devam ederse. Ancak, yat\u0131r\u0131mc\u0131lar\u0131n fiyat e\u011filimlerini etkileyebilecek genel piyasa dalgalanmalar\u0131 ve makroekonomik ko\u015fullar gibi risk fakt\u00f6rlerine dikkat etmeleri gerekmektedir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Dikkate De\u011fer Teknik Formasyonlar<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Son zamanlarda, GPC hisse senedi \"Kupa ve Kulplu\" bir formasyon olu\u015fturdu - g\u00fc\u00e7l\u00fc fiyat k\u0131r\u0131lma potansiyelini i\u015faret eden bir teknik formasyon. \"Kupa\", 2024'\u00fcn ilk 4 ay\u0131nda olu\u015ftu, ard\u0131ndan yakla\u015f\u0131k 6-8 hafta s\u00fcren bir \"kulplu\" a\u015fama geldi. Teknik analiz teorisine g\u00f6re, bu formasyon tamamland\u0131ktan sonra fiyat hedefi mevcut fiyat seviyesinden %15-20 daha y\u00fcksek olabilir.<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\"Kupa ve Kulplu\" formasyonu genellikle g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f trendini i\u015faret eder<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse senedi kupa kenar\u0131n\u0131n \u00fczerine \u00e7\u0131kt\u0131\u011f\u0131nda artan i\u015flem hacmi \u00f6nemli bir onay sinyalidir<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Bu formasyon tamamlan\u0131rsa fiyat hedefi 72,000-75,000 VND'ye ula\u015fabilir<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>GPC Hisse Senedi Beklentilerini Etkileyen Makroekonomik Fakt\u00f6rler<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Makroekonomik ortam, GPC hisse senedinin beklentilerini \u015fekillendirmede \u00f6nemli bir rol oynamaktad\u0131r. 2025 y\u0131l\u0131nda, Vietnam ekonomisinin yakla\u015f\u0131k %6.5-7 oran\u0131nda b\u00fcy\u00fcmesi, enflasyonun ise %3.5-4 oran\u0131nda kontrol alt\u0131nda tutulmas\u0131 \u00f6ng\u00f6r\u00fclmektedir. Devam eden d\u00fc\u015f\u00fck faiz oranlar\u0131, i\u015fletmelerin yat\u0131r\u0131m geni\u015fletmesi i\u00e7in elveri\u015fli ko\u015fullar yaratacakt\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Vietnam'\u0131n ila\u00e7 sekt\u00f6r\u00fc bir\u00e7ok olumlu trendden faydalanmaktad\u0131r. \u0130lk olarak, ya\u015flanan n\u00fcfus ve b\u00fcy\u00fcyen orta s\u0131n\u0131f, sa\u011fl\u0131k hizmetleri ve y\u00fcksek kaliteli ila\u00e7lara olan talebi art\u0131rmaktad\u0131r. \u0130kincisi, H\u00fck\u00fcmetin evrensel sa\u011fl\u0131k sigortas\u0131 politikas\u0131, pazar\u0131 geni\u015fletmeye ve yerli ila\u00e7lar i\u00e7in istikrarl\u0131 talep yaratmaya yard\u0131mc\u0131 olmaktad\u0131r. \u00dc\u00e7\u00fcnc\u00fcs\u00fc, \"Vietnam'da \u00dcret\" trendi ve kamu sa\u011fl\u0131k tesislerinde ihalelerde yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar, Imexpharm gibi yerli ila\u00e7 \u015firketleri i\u00e7in avantajlar yaratmaktad\u0131r.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Makroekonomik Fakt\u00f6r<\/th><th>GPC \u00dczerindeki Etki<\/th><\/tr><\/thead><tbody><tr><td>GSY\u0130H b\u00fcy\u00fcmesi %6.5-7<\/td><td>Pozitif<\/td><\/tr><tr><td>%3.5-4 oran\u0131nda kontrol edilen enflasyon<\/td><td>Pozitif<\/td><\/tr><tr><td>D\u00fc\u015f\u00fck faiz oranlar\u0131<\/td><td>Pozitif<\/td><\/tr><tr><td>Yerli ila\u00e7 tercih politikas\u0131<\/td><td>\u00c7ok pozitif<\/td><\/tr><tr><td>Ya\u015flanan n\u00fcfus<\/td><td>Uzun vadeli pozitif<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>\u00d6zellikle, 2024'ten itibaren tam olarak y\u00fcr\u00fcrl\u00fc\u011fe giren EVFTA (AB-Vietnam Serbest Ticaret Anla\u015fmas\u0131), Imexpharm gibi AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan \u015firketler i\u00e7in AB pazar\u0131na ila\u00e7 ihracat\u0131 f\u0131rsatlar\u0131 a\u00e7maktad\u0131r. Bu, \u015firket i\u00e7in pazar\u0131n\u0131 geni\u015fletmek ve \u00f6n\u00fcm\u00fczdeki y\u0131llarda ihracat gelirini art\u0131rmak i\u00e7in b\u00fcy\u00fck bir f\u0131rsatt\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Ancak, risk fakt\u00f6rleri de dikkate al\u0131nmal\u0131d\u0131r. G\u00fc\u00e7l\u00fc finansal kapasiteye ve ileri teknolojiye sahip yabanc\u0131 ila\u00e7 \u015firketlerinden gelen rekabet giderek artmaktad\u0131r. D\u00f6viz kuru dalgalanmalar\u0131 ve d\u00fcnya pazar\u0131ndaki ila\u00e7 hammaddesi fiyatlar\u0131 nedeniyle artan girdi maliyetleri de \u00f6nemli zorluklard\u0131r. Ayr\u0131ca, ila\u00e7 y\u00f6netim politikalar\u0131ndaki ve ila\u00e7 ihale s\u00fcre\u00e7lerindeki de\u011fi\u015fiklikler, \u015firketin i\u015f sonu\u00e7lar\u0131n\u0131 etkileyebilir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>2025 Y\u0131l\u0131nda GPC Hisse Senedi \u0130\u00e7in Uygun Yat\u0131r\u0131m Stratejileri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Temel analiz, teknik analiz ve makroekonomik fakt\u00f6rlere dayanarak, Pocket Option'daki uzmanlar 2025 y\u0131l\u0131nda GPC hisse senedi i\u00e7in birka\u00e7 uygun yat\u0131r\u0131m stratejisi \u00f6nermektedir:<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Holding S\u00fcresine G\u00f6re Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/h3><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Uzun vadeli yat\u0131r\u0131m (12+ ay): \u015eirketin s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmesinden ve d\u00fczenli temett\u00fclerden getiri arayan yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur. Portf\u00f6y\u00fcn %5-10'unu GPC'ye ay\u0131rabilir.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Orta vadeli yat\u0131r\u0131m (3-6 ay): Hisse senedinin mevcut y\u00fckseli\u015f trendini ve 2025'teki g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyelini de\u011ferlendirin.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>K\u0131sa vadeli ticaret: Sadece deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur, teknik sinyallere ve k\u0131sa vadeli fiyat hareketlerine dayan\u0131r.<\/li><\/ul><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Yat\u0131r\u0131mc\u0131 T\u00fcr\u00fc<\/th><th>Strateji<\/th><th>Al\u0131m Zaman\u0131<\/th><th>Fiyat Hedefi<\/th><th>Zarar Durdurma<\/th><\/tr><\/thead><tbody><tr><td>Uzun vadeli<\/td><td>Kademeli birikim<\/td><td>MA200 civar\u0131nda fiyat<\/td><td>75,000-80,000<\/td><td>MA200 alt\u0131nda uzun s\u00fcre<\/td><\/tr><tr><td>Orta vadeli<\/td><td>K\u0131r\u0131lmada al\u0131m<\/td><td>65,000 \u00fczerinde hacimle k\u0131r\u0131lma<\/td><td>72,000-75,000<\/td><td>58,000 alt\u0131nda<\/td><\/tr><tr><td>K\u0131sa vadeli<\/td><td>Swing ticareti<\/td><td>Ba\u015far\u0131l\u0131 destek testi<\/td><td>65,000-68,000<\/td><td>En yak\u0131n deste\u011fin alt\u0131na k\u0131r\u0131lma<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, dolar-maliyet ortalamas\u0131 stratejisi uygundur, yani k\u0131sa vadeli fiyat dalgalanmalar\u0131na bak\u0131lmaks\u0131z\u0131n ayl\u0131k veya \u00fc\u00e7 ayl\u0131k olarak d\u00fczenli olarak GPC hisse senedi al\u0131m\u0131 yapmak. Bu strateji, piyasa dalgaland\u0131\u011f\u0131nda riski minimize etmeye ve uzun vadede ortalama maliyet baz\u0131n\u0131 optimize etmeye yard\u0131mc\u0131 olur.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Orta vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, GPC hisse senedi \u00f6nemli destek seviyelerine, \u00f6rne\u011fin MA50 veya MA200'e d\u00fczeltme yapt\u0131\u011f\u0131nda f\u0131rsatlara dikkat edilmelidir. Bunlar genellikle kat\u0131lmak veya maruziyeti art\u0131rmak i\u00e7in elveri\u015fli zamanlard\u0131r. \u00d6n\u00fcm\u00fczdeki 6-12 ayda fiyat hedefi, mevcut fiyattan %15-20 art\u0131\u015fla 72,000-75,000 VND'ye ula\u015fabilir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, teknik analizi piyasa para ak\u0131\u015f\u0131n\u0131 ve \u015firket bilgilerini izlemekle birle\u015ftirmek etkili bir stratejidir. RSI, MACD g\u00f6stergelerinden ve mum \u00e7ubu\u011fu formasyonlar\u0131ndan gelen sinyaller, do\u011fru giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 sa\u011flayabilir. \"Destekte al, diren\u00e7te sat\" stratejisi, y\u00fckseli\u015f trendinde olan bir hisse senedi ba\u011flam\u0131nda uygundur.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option'daki uzmanlar, yat\u0131r\u0131mc\u0131lar\u0131n yat\u0131r\u0131m portf\u00f6ylerini \u00e7e\u015fitlendirmelerini, tek bir hisse senedine \u00e7ok fazla odaklanmamalar\u0131n\u0131 \u00f6nermektedir. GPC, her ki\u015finin risk i\u015ftah\u0131na ve yat\u0131r\u0131m hedeflerine ba\u011fl\u0131 olarak portf\u00f6yde makul bir oranda yer almal\u0131d\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>GPC'ye Yat\u0131r\u0131m Yaparken Riskler ve Risk Y\u00f6netimi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>GPC hisse senedinin g\u00f6r\u00fcn\u00fcm\u00fc olduk\u00e7a olumlu olsa da, yat\u0131r\u0131mc\u0131lar yine de a\u015fa\u011f\u0131daki riskleri tan\u0131mlamal\u0131 ve y\u00f6netmelidir:<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Sekt\u00f6r riskleri: \u0130la\u00e7 sekt\u00f6r\u00fcnde yo\u011fun rekabet, ila\u00e7 fiyat y\u00f6netim politikalar\u0131ndaki de\u011fi\u015fiklikler<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Makroekonomik riskler: D\u00f6viz kuru dalgalanmalar\u0131, girdi maliyetlerini etkileyen y\u00fcksek enflasyon<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u0130\u015fletme riskleri: \u0130\u015f sonu\u00e7lar\u0131n\u0131n beklentileri kar\u015f\u0131lamamas\u0131, yeni yat\u0131r\u0131m projelerinin gecikmesi<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Piyasa riskleri: Yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131n\u0131 etkileyen genel piyasa dalgalanmalar\u0131<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Riski etkili bir \u015fekilde y\u00f6netmek i\u00e7in, yat\u0131r\u0131mc\u0131lar a\u015fa\u011f\u0131daki ilkeleri uygulamal\u0131d\u0131r:<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>\u0130lke<\/th><th>Uygulama<\/th><\/tr><\/thead><tbody><tr><td>Portf\u00f6y \u00e7e\u015fitlendirmesi<\/td><td>Portf\u00f6y\u00fcn %10'undan fazlas\u0131n\u0131 tek bir hisse senedine yat\u0131rmay\u0131n<\/td><\/tr><tr><td>Zarar durdurma emirleri belirleme<\/td><td>Fiyat, al\u0131m fiyat\u0131ndan %7-10 d\u00fc\u015ft\u00fc\u011f\u00fcnde zarar\u0131 kesin<\/td><\/tr><tr><td>Sermaye tahsisini a\u015famal\u0131 yapma<\/td><td>Al\u0131m emirlerini birden fazla partiye b\u00f6l\u00fcn<\/td><\/tr><tr><td>Bilgi g\u00fcncellemeleri<\/td><td>\u0130\u015f sonu\u00e7lar\u0131n\u0131 ve \u015firket bilgilerini yak\u0131ndan izleyin<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Ayr\u0131ca, yat\u0131r\u0131mc\u0131lar Pocket Option platformundaki Zarar Durdurma, Kar Al ve teknik analiz \u00f6zellikleri gibi risk y\u00f6netim ara\u00e7lar\u0131n\u0131 kullanarak yat\u0131r\u0131m portf\u00f6ylerini zaman\u0131nda izleyip ayarlayabilirler.<\/p><\/div>[cta_button text=\"\"]<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>2025 Y\u0131l\u0131nda GPC Hisse Senedi Yat\u0131r\u0131m F\u0131rsatlar\u0131 \u00dczerine Sonu\u00e7<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>\u00d6zetle, Imexpharm Pharmaceutical Joint Stock Company'nin GPC hisse senedi, 2025 y\u0131l\u0131nda olumlu yat\u0131r\u0131m potansiyeli g\u00f6stermektedir. Sa\u011flam bir temel altyap\u0131, istikrarl\u0131 i\u015f b\u00fcy\u00fcmesi ve makul de\u011ferleme ile GPC, hem uzun vadeli hem de orta vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli bir se\u00e7enektir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>B\u00fcy\u00fcmeyi destekleyen fakt\u00f6rler \u015funlard\u0131r: (1) Vietnam'\u0131n ila\u00e7 sekt\u00f6r\u00fc g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme d\u00f6ng\u00fcs\u00fcnde; (2) Yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar; (3) Yeni fabrika ile art\u0131r\u0131lm\u0131\u015f \u00fcretim ve Ar-Ge kapasitesi; (4) AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layarak ihracat pazarlar\u0131n\u0131 geni\u015fletme yetene\u011fi.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Ancak, yat\u0131r\u0131mc\u0131lar\u0131n potansiyel risklere dikkat etmeleri ve uygun risk y\u00f6netim stratejileri uygulamalar\u0131 gerekmektedir. \u00d6zellikle, \u00fc\u00e7 ayl\u0131k i\u015f sonu\u00e7lar\u0131 raporlar\u0131n\u0131, yeni yat\u0131r\u0131m projeleri hakk\u0131ndaki bilgileri ve ila\u00e7 sekt\u00f6r\u00fc politikalar\u0131n\u0131 yak\u0131ndan izleyerek yat\u0131r\u0131m stratejilerine zaman\u0131nda ayarlamalar yapmalar\u0131 gerekmektedir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option uzman tahminlerine g\u00f6re, mevcut b\u00fcy\u00fcme ivmesiyle, \u00f6n\u00fcm\u00fczdeki 12 ayda GPC hisse senedi i\u00e7in makul bir fiyat hedefi, mevcut fiyattan %15-20 art\u0131\u015fla 72,000-75,000 VND'dir. Bu, yakla\u015f\u0131k %3.5'lik bir temett\u00fc ile birle\u015ftirildi\u011finde, yat\u0131r\u0131mc\u0131lar i\u00e7in %20'nin \u00fczerinde potansiyel toplam getiri sa\u011flayan \u00e7ekici bir getiridir.<\/p><\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>GPC Hisse Senedi ve Vietnam&#8217;\u0131n \u0130la\u00e7 Sekt\u00f6r\u00fcndeki Konumu \u00dczerine Genel Bak\u0131\u015f<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>GPC hisse senedi, 1977 y\u0131l\u0131nda kurulan Vietnam&#8217;\u0131n \u00f6nde gelen ila\u00e7 i\u015fletmelerinden biri olan Imexpharm Pharmaceutical Joint Stock Company&#8217;ye aittir. 40 y\u0131l\u0131 a\u015fk\u0131n bir geli\u015fim s\u00fcreciyle Imexpharm, yerel ve b\u00f6lgesel ila\u00e7 pazarlar\u0131nda sa\u011flam bir konum olu\u015fturmu\u015ftur. \u015eirket, \u00f6zellikle antibiyotikler ve fonksiyonel g\u0131dalar olmak \u00fczere y\u00fcksek kaliteli ila\u00e7 \u00fcr\u00fcnlerinin \u00fcretimi ve ticareti konusunda uzmanla\u015fm\u0131\u015ft\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Vietnam&#8217;\u0131n h\u0131zla geli\u015fen ila\u00e7 sekt\u00f6r\u00fc ba\u011flam\u0131nda, GPC hisse senedi giderek daha fazla yat\u0131r\u0131mc\u0131 ilgisini \u00e7ekmektedir. Vietnam ila\u00e7 pazar\u0131n\u0131n, 2023-2028 d\u00f6neminde y\u0131ll\u0131k bile\u015fik b\u00fcy\u00fcme oran\u0131 (CAGR) olarak yakla\u015f\u0131k %10-12 oran\u0131nda b\u00fcy\u00fcmesi \u00f6ng\u00f6r\u00fclmektedir, bu da k\u00fcresel ortalaman\u0131n \u00fczerindedir. Bu, Imexpharm dahil olmak \u00fczere yerli ila\u00e7 \u015firketlerinin geli\u015fim beklentileri i\u00e7in \u00f6nemli bir itici g\u00fc\u00e7t\u00fcr.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Rekabet\u00e7i konum a\u00e7\u0131s\u0131ndan, Imexpharm, AB-GMP ve WHO-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan y\u00fcksek kaliteli \u00fcr\u00fcn hatlar\u0131na odaklanarak s\u00fcrd\u00fcr\u00fclebilir bir geli\u015fim stratejisi ile \u00f6ne \u00e7\u0131kmaktad\u0131r. Bu, \u00f6zellikle Vietnaml\u0131 t\u00fcketicilerin ila\u00e7 kalitesine giderek daha fazla \u00f6nem vermesi ve yerli \u00fcretilen ila\u00e7lar\u0131n kullan\u0131m trendinin artmas\u0131yla \u00f6nemli bir rekabet avantaj\u0131d\u0131r. 2024 y\u0131l\u0131nda Imexpharm, \u00fcretim kapasitesini art\u0131ran ve \u00fcr\u00fcn portf\u00f6y\u00fcn\u00fc geni\u015fleten y\u00fcksek teknoloji bir antibiyotik \u00fcretim tesisi a\u00e7m\u0131\u015ft\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>G\u00f6sterge<\/th>\n<th>2022<\/th>\n<th>2023<\/th>\n<th>2024<\/th>\n<th>2025 Tahmin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Gelir (milyar VND)<\/td>\n<td>1,480<\/td>\n<td>1,650<\/td>\n<td>1,842<\/td>\n<td>2,100<\/td>\n<\/tr>\n<tr>\n<td>Net Kar (milyar VND)<\/td>\n<td>248<\/td>\n<td>290<\/td>\n<td>325<\/td>\n<td>380<\/td>\n<\/tr>\n<tr>\n<td>EPS (VND)<\/td>\n<td>3,750<\/td>\n<td>4,200<\/td>\n<td>4,650<\/td>\n<td>5,400<\/td>\n<\/tr>\n<tr>\n<td>ROE (%)<\/td>\n<td>14.2<\/td>\n<td>15.3<\/td>\n<td>16.1<\/td>\n<td>17.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>GPC Hisse Senedinin Temel ve Finansal Analizi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Temel analiz, GPC hisse senedinin potansiyelini de\u011ferlendirirken \u00f6nemli bir ad\u0131md\u0131r. Imexpharm&#8217;\u0131n son y\u0131llardaki i\u015f sonu\u00e7lar\u0131 istikrarl\u0131 bir b\u00fcy\u00fcme g\u00f6stermektedir. 2024 y\u0131l\u0131nda \u015firket, 2023&#8217;e g\u00f6re %11.6 art\u0131\u015fla 1,842 milyar VND gelir elde etti. Net kar, bir \u00f6nceki y\u0131la g\u00f6re %12.1 art\u0131\u015fla 325 milyar VND&#8217;ye ula\u015ft\u0131. Bu, hala bir\u00e7ok zorlukla kar\u015f\u0131 kar\u015f\u0131ya olan bir pazarda etkileyici bir b\u00fcy\u00fcmedir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Imexpharm&#8217;\u0131n finansal g\u00f6stergeleri de olduk\u00e7a olumlu. Br\u00fct kar marj\u0131, sekt\u00f6r ortalamas\u0131n\u0131n \u00fczerinde, %38-40 seviyesinde korunmaktad\u0131r. ROE (\u00d6zsermaye Getirisi) 2024 y\u0131l\u0131nda %16.1&#8217;e ula\u015farak, 2023&#8217;teki %15.3&#8217;ten y\u00fckselmi\u015ftir. Mevcut F\/K oran\u0131 yakla\u015f\u0131k 12-13 kat civar\u0131ndad\u0131r, bu da ila\u00e7 sekt\u00f6r\u00fc ortalamas\u0131 olan yakla\u015f\u0131k 15-16 kat\u0131n alt\u0131nda olup, hissenin fiyat de\u011ferleme potansiyelini g\u00f6stermektedir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>De\u011ferleme Metrikleri Analizi<\/h3>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>G\u00f6sterge<\/th>\n<th>GPC<\/th>\n<th>Sekt\u00f6r Ortalamas\u0131<\/th>\n<th>De\u011ferlendirme<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>F\/K<\/td>\n<td>12.5<\/td>\n<td>15.8<\/td>\n<td>Cazip<\/td>\n<\/tr>\n<tr>\n<td>P\/B<\/td>\n<td>1.98<\/td>\n<td>2.25<\/td>\n<td>Makul<\/td>\n<\/tr>\n<tr>\n<td>EV\/EBITDA<\/td>\n<td>8.2<\/td>\n<td>9.5<\/td>\n<td>Cazip<\/td>\n<\/tr>\n<tr>\n<td>Temett\u00fc Verimi (%)<\/td>\n<td>3.5<\/td>\n<td>2.8<\/td>\n<td>\u0130yi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Finansal durum a\u00e7\u0131s\u0131ndan, Imexpharm d\u00fc\u015f\u00fck bor\u00e7-\u00f6zsermaye oran\u0131 (yakla\u015f\u0131k 0.3 kat) ile sa\u011fl\u0131kl\u0131 bir sermaye yap\u0131s\u0131na sahiptir. \u015eirket, toplam varl\u0131klar\u0131n yakla\u015f\u0131k %15&#8217;ini olu\u015fturan bol miktarda nakde sahiptir, bu da i\u015fin geni\u015fleme projelerini ve yeni \u00fcr\u00fcnlerin ara\u015ft\u0131rma ve geli\u015ftirmesini finanse etmek i\u00e7in yeterli kaynaklara sahip olmas\u0131n\u0131 sa\u011flar. \u00d6zellikle, faiz oranlar\u0131n\u0131n d\u00fc\u015ft\u00fc\u011f\u00fc mevcut ba\u011flamda, Imexpharm&#8217;\u0131n d\u00fc\u015f\u00fck borcu \u00f6nemli bir avantajd\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Dikkate de\u011fer bir di\u011fer nokta ise \u015firketin temett\u00fc politikas\u0131d\u0131r. Imexpharm, hissedarlara kar payla\u015f\u0131m taahh\u00fcd\u00fcn\u00fc g\u00f6stererek, nakit ve hisse olarak yakla\u015f\u0131k %15-20 oran\u0131nda d\u00fczenli temett\u00fc \u00f6demeleri yapmaktad\u0131r. Mevcut fiyatla, GPC hisse senedinin temett\u00fc verimi, banka mevduat faiz oranlar\u0131n\u0131n ve sekt\u00f6r ortalamas\u0131n\u0131n \u00fczerinde, yakla\u015f\u0131k %3.5&#8217;tir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>GPC Hisse Senedinin Teknik Analizi ve Ticaret E\u011filimleri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Teknik analiz, yat\u0131r\u0131mc\u0131lar i\u00e7in fiyat e\u011filimleri ve ideal giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 hakk\u0131nda de\u011ferli bilgiler sa\u011flar. Teknik grafiklere g\u00f6re, GPC hisse senedi 2024&#8217;\u00fcn ilk alt\u0131 ay\u0131nda birikim a\u015famas\u0131ndan ge\u00e7ti ve 2024&#8217;\u00fcn \u00fc\u00e7\u00fcnc\u00fc \u00e7eyre\u011finden itibaren bir y\u00fckseli\u015f trendine ba\u015flad\u0131. \u015eu anda, hisse senedi MA50 (50 g\u00fcnl\u00fck hareketli ortalama) ve MA200 (200 g\u00fcnl\u00fck hareketli ortalama) \u00fczerinde i\u015flem g\u00f6rmekte olup, orta ve uzun vadeli yukar\u0131 y\u00f6nl\u00fc trendleri do\u011frulamaktad\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>RSI (G\u00f6receli G\u00fc\u00e7 Endeksi) gibi teknik g\u00f6stergeler 65 seviyesinde olup, hissenin hen\u00fcz a\u015f\u0131r\u0131 al\u0131m b\u00f6lgesinde olmad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir. MACD de sinyal \u00e7izgisinin \u00fczerinde pozitif momentum ile bulunmaktad\u0131r. Son 20 seansta ortalama i\u015flem hacmi, \u00f6nceki 20 seansa g\u00f6re %30 artarak yat\u0131r\u0131mc\u0131 ilgisinin artt\u0131\u011f\u0131n\u0131 yans\u0131tmaktad\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Teknik G\u00f6sterge<\/th>\n<th>Mevcut De\u011fer<\/th>\n<th>Sinyal<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>RSI (14)<\/td>\n<td>65<\/td>\n<td>Pozitif<\/td>\n<\/tr>\n<tr>\n<td>MACD (12,26,9)<\/td>\n<td>+2.15<\/td>\n<td>Al<\/td>\n<\/tr>\n<tr>\n<td>Bollinger Bantlar\u0131<\/td>\n<td>\u00dcst banda yak\u0131n i\u015flem g\u00f6r\u00fcyor<\/td>\n<td>Pozitif<\/td>\n<\/tr>\n<tr>\n<td>Stokastik<\/td>\n<td>82<\/td>\n<td>A\u015f\u0131r\u0131 al\u0131m b\u00f6lgesine yak\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Diren\u00e7 ve destek seviyeleri a\u00e7\u0131s\u0131ndan, GPC hisse senedi \u015fu anda 65,000 VND fiyat seviyesinde, ticaret tarihindeki en y\u00fcksek zirveye kar\u015f\u0131l\u0131k gelen g\u00fc\u00e7l\u00fc bir dirence sahiptir. \u00d6nemli destek seviyeleri 58,000 VND (MA50) ve 52,000 VND (MA200) seviyelerindedir. Uygun bir ticaret stratejisi, bu destek seviyelerinde al\u0131mlar\u0131 biriktirmek ve diren\u00e7 b\u00f6lgelerine yakla\u015f\u0131ld\u0131\u011f\u0131nda k\u0131smi kar almay\u0131 d\u00fc\u015f\u00fcnmektir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option&#8217;daki analistlere g\u00f6re, mevcut momentumla, GPC hisse senedinin 2025&#8217;in ikinci \u00e7eyre\u011finde 65,000 VND diren\u00e7 seviyesini a\u015fmas\u0131 muhtemeldir, \u00f6zellikle 2025&#8217;in ilk \u00e7eyre\u011fi i\u015f sonu\u00e7lar\u0131 olumlu olmaya devam ederse. Ancak, yat\u0131r\u0131mc\u0131lar\u0131n fiyat e\u011filimlerini etkileyebilecek genel piyasa dalgalanmalar\u0131 ve makroekonomik ko\u015fullar gibi risk fakt\u00f6rlerine dikkat etmeleri gerekmektedir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Dikkate De\u011fer Teknik Formasyonlar<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Son zamanlarda, GPC hisse senedi &#8220;Kupa ve Kulplu&#8221; bir formasyon olu\u015fturdu &#8211; g\u00fc\u00e7l\u00fc fiyat k\u0131r\u0131lma potansiyelini i\u015faret eden bir teknik formasyon. &#8220;Kupa&#8221;, 2024&#8217;\u00fcn ilk 4 ay\u0131nda olu\u015ftu, ard\u0131ndan yakla\u015f\u0131k 6-8 hafta s\u00fcren bir &#8220;kulplu&#8221; a\u015fama geldi. Teknik analiz teorisine g\u00f6re, bu formasyon tamamland\u0131ktan sonra fiyat hedefi mevcut fiyat seviyesinden %15-20 daha y\u00fcksek olabilir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>&#8220;Kupa ve Kulplu&#8221; formasyonu genellikle g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f trendini i\u015faret eder<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse senedi kupa kenar\u0131n\u0131n \u00fczerine \u00e7\u0131kt\u0131\u011f\u0131nda artan i\u015flem hacmi \u00f6nemli bir onay sinyalidir<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Bu formasyon tamamlan\u0131rsa fiyat hedefi 72,000-75,000 VND&#8217;ye ula\u015fabilir<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>GPC Hisse Senedi Beklentilerini Etkileyen Makroekonomik Fakt\u00f6rler<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Makroekonomik ortam, GPC hisse senedinin beklentilerini \u015fekillendirmede \u00f6nemli bir rol oynamaktad\u0131r. 2025 y\u0131l\u0131nda, Vietnam ekonomisinin yakla\u015f\u0131k %6.5-7 oran\u0131nda b\u00fcy\u00fcmesi, enflasyonun ise %3.5-4 oran\u0131nda kontrol alt\u0131nda tutulmas\u0131 \u00f6ng\u00f6r\u00fclmektedir. Devam eden d\u00fc\u015f\u00fck faiz oranlar\u0131, i\u015fletmelerin yat\u0131r\u0131m geni\u015fletmesi i\u00e7in elveri\u015fli ko\u015fullar yaratacakt\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Vietnam&#8217;\u0131n ila\u00e7 sekt\u00f6r\u00fc bir\u00e7ok olumlu trendden faydalanmaktad\u0131r. \u0130lk olarak, ya\u015flanan n\u00fcfus ve b\u00fcy\u00fcyen orta s\u0131n\u0131f, sa\u011fl\u0131k hizmetleri ve y\u00fcksek kaliteli ila\u00e7lara olan talebi art\u0131rmaktad\u0131r. \u0130kincisi, H\u00fck\u00fcmetin evrensel sa\u011fl\u0131k sigortas\u0131 politikas\u0131, pazar\u0131 geni\u015fletmeye ve yerli ila\u00e7lar i\u00e7in istikrarl\u0131 talep yaratmaya yard\u0131mc\u0131 olmaktad\u0131r. \u00dc\u00e7\u00fcnc\u00fcs\u00fc, &#8220;Vietnam&#8217;da \u00dcret&#8221; trendi ve kamu sa\u011fl\u0131k tesislerinde ihalelerde yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar, Imexpharm gibi yerli ila\u00e7 \u015firketleri i\u00e7in avantajlar yaratmaktad\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Makroekonomik Fakt\u00f6r<\/th>\n<th>GPC \u00dczerindeki Etki<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>GSY\u0130H b\u00fcy\u00fcmesi %6.5-7<\/td>\n<td>Pozitif<\/td>\n<\/tr>\n<tr>\n<td>%3.5-4 oran\u0131nda kontrol edilen enflasyon<\/td>\n<td>Pozitif<\/td>\n<\/tr>\n<tr>\n<td>D\u00fc\u015f\u00fck faiz oranlar\u0131<\/td>\n<td>Pozitif<\/td>\n<\/tr>\n<tr>\n<td>Yerli ila\u00e7 tercih politikas\u0131<\/td>\n<td>\u00c7ok pozitif<\/td>\n<\/tr>\n<tr>\n<td>Ya\u015flanan n\u00fcfus<\/td>\n<td>Uzun vadeli pozitif<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>\u00d6zellikle, 2024&#8217;ten itibaren tam olarak y\u00fcr\u00fcrl\u00fc\u011fe giren EVFTA (AB-Vietnam Serbest Ticaret Anla\u015fmas\u0131), Imexpharm gibi AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan \u015firketler i\u00e7in AB pazar\u0131na ila\u00e7 ihracat\u0131 f\u0131rsatlar\u0131 a\u00e7maktad\u0131r. Bu, \u015firket i\u00e7in pazar\u0131n\u0131 geni\u015fletmek ve \u00f6n\u00fcm\u00fczdeki y\u0131llarda ihracat gelirini art\u0131rmak i\u00e7in b\u00fcy\u00fck bir f\u0131rsatt\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Ancak, risk fakt\u00f6rleri de dikkate al\u0131nmal\u0131d\u0131r. G\u00fc\u00e7l\u00fc finansal kapasiteye ve ileri teknolojiye sahip yabanc\u0131 ila\u00e7 \u015firketlerinden gelen rekabet giderek artmaktad\u0131r. D\u00f6viz kuru dalgalanmalar\u0131 ve d\u00fcnya pazar\u0131ndaki ila\u00e7 hammaddesi fiyatlar\u0131 nedeniyle artan girdi maliyetleri de \u00f6nemli zorluklard\u0131r. Ayr\u0131ca, ila\u00e7 y\u00f6netim politikalar\u0131ndaki ve ila\u00e7 ihale s\u00fcre\u00e7lerindeki de\u011fi\u015fiklikler, \u015firketin i\u015f sonu\u00e7lar\u0131n\u0131 etkileyebilir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>2025 Y\u0131l\u0131nda GPC Hisse Senedi \u0130\u00e7in Uygun Yat\u0131r\u0131m Stratejileri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Temel analiz, teknik analiz ve makroekonomik fakt\u00f6rlere dayanarak, Pocket Option&#8217;daki uzmanlar 2025 y\u0131l\u0131nda GPC hisse senedi i\u00e7in birka\u00e7 uygun yat\u0131r\u0131m stratejisi \u00f6nermektedir:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Holding S\u00fcresine G\u00f6re Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Uzun vadeli yat\u0131r\u0131m (12+ ay): \u015eirketin s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmesinden ve d\u00fczenli temett\u00fclerden getiri arayan yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur. Portf\u00f6y\u00fcn %5-10&#8217;unu GPC&#8217;ye ay\u0131rabilir.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Orta vadeli yat\u0131r\u0131m (3-6 ay): Hisse senedinin mevcut y\u00fckseli\u015f trendini ve 2025&#8217;teki g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyelini de\u011ferlendirin.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>K\u0131sa vadeli ticaret: Sadece deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur, teknik sinyallere ve k\u0131sa vadeli fiyat hareketlerine dayan\u0131r.<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Yat\u0131r\u0131mc\u0131 T\u00fcr\u00fc<\/th>\n<th>Strateji<\/th>\n<th>Al\u0131m Zaman\u0131<\/th>\n<th>Fiyat Hedefi<\/th>\n<th>Zarar Durdurma<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Uzun vadeli<\/td>\n<td>Kademeli birikim<\/td>\n<td>MA200 civar\u0131nda fiyat<\/td>\n<td>75,000-80,000<\/td>\n<td>MA200 alt\u0131nda uzun s\u00fcre<\/td>\n<\/tr>\n<tr>\n<td>Orta vadeli<\/td>\n<td>K\u0131r\u0131lmada al\u0131m<\/td>\n<td>65,000 \u00fczerinde hacimle k\u0131r\u0131lma<\/td>\n<td>72,000-75,000<\/td>\n<td>58,000 alt\u0131nda<\/td>\n<\/tr>\n<tr>\n<td>K\u0131sa vadeli<\/td>\n<td>Swing ticareti<\/td>\n<td>Ba\u015far\u0131l\u0131 destek testi<\/td>\n<td>65,000-68,000<\/td>\n<td>En yak\u0131n deste\u011fin alt\u0131na k\u0131r\u0131lma<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, dolar-maliyet ortalamas\u0131 stratejisi uygundur, yani k\u0131sa vadeli fiyat dalgalanmalar\u0131na bak\u0131lmaks\u0131z\u0131n ayl\u0131k veya \u00fc\u00e7 ayl\u0131k olarak d\u00fczenli olarak GPC hisse senedi al\u0131m\u0131 yapmak. Bu strateji, piyasa dalgaland\u0131\u011f\u0131nda riski minimize etmeye ve uzun vadede ortalama maliyet baz\u0131n\u0131 optimize etmeye yard\u0131mc\u0131 olur.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Orta vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, GPC hisse senedi \u00f6nemli destek seviyelerine, \u00f6rne\u011fin MA50 veya MA200&#8217;e d\u00fczeltme yapt\u0131\u011f\u0131nda f\u0131rsatlara dikkat edilmelidir. Bunlar genellikle kat\u0131lmak veya maruziyeti art\u0131rmak i\u00e7in elveri\u015fli zamanlard\u0131r. \u00d6n\u00fcm\u00fczdeki 6-12 ayda fiyat hedefi, mevcut fiyattan %15-20 art\u0131\u015fla 72,000-75,000 VND&#8217;ye ula\u015fabilir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in, teknik analizi piyasa para ak\u0131\u015f\u0131n\u0131 ve \u015firket bilgilerini izlemekle birle\u015ftirmek etkili bir stratejidir. RSI, MACD g\u00f6stergelerinden ve mum \u00e7ubu\u011fu formasyonlar\u0131ndan gelen sinyaller, do\u011fru giri\u015f\/\u00e7\u0131k\u0131\u015f noktalar\u0131 sa\u011flayabilir. &#8220;Destekte al, diren\u00e7te sat&#8221; stratejisi, y\u00fckseli\u015f trendinde olan bir hisse senedi ba\u011flam\u0131nda uygundur.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option&#8217;daki uzmanlar, yat\u0131r\u0131mc\u0131lar\u0131n yat\u0131r\u0131m portf\u00f6ylerini \u00e7e\u015fitlendirmelerini, tek bir hisse senedine \u00e7ok fazla odaklanmamalar\u0131n\u0131 \u00f6nermektedir. GPC, her ki\u015finin risk i\u015ftah\u0131na ve yat\u0131r\u0131m hedeflerine ba\u011fl\u0131 olarak portf\u00f6yde makul bir oranda yer almal\u0131d\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>GPC&#8217;ye Yat\u0131r\u0131m Yaparken Riskler ve Risk Y\u00f6netimi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>GPC hisse senedinin g\u00f6r\u00fcn\u00fcm\u00fc olduk\u00e7a olumlu olsa da, yat\u0131r\u0131mc\u0131lar yine de a\u015fa\u011f\u0131daki riskleri tan\u0131mlamal\u0131 ve y\u00f6netmelidir:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Sekt\u00f6r riskleri: \u0130la\u00e7 sekt\u00f6r\u00fcnde yo\u011fun rekabet, ila\u00e7 fiyat y\u00f6netim politikalar\u0131ndaki de\u011fi\u015fiklikler<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Makroekonomik riskler: D\u00f6viz kuru dalgalanmalar\u0131, girdi maliyetlerini etkileyen y\u00fcksek enflasyon<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u0130\u015fletme riskleri: \u0130\u015f sonu\u00e7lar\u0131n\u0131n beklentileri kar\u015f\u0131lamamas\u0131, yeni yat\u0131r\u0131m projelerinin gecikmesi<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Piyasa riskleri: Yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131n\u0131 etkileyen genel piyasa dalgalanmalar\u0131<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Riski etkili bir \u015fekilde y\u00f6netmek i\u00e7in, yat\u0131r\u0131mc\u0131lar a\u015fa\u011f\u0131daki ilkeleri uygulamal\u0131d\u0131r:<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>\u0130lke<\/th>\n<th>Uygulama<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Portf\u00f6y \u00e7e\u015fitlendirmesi<\/td>\n<td>Portf\u00f6y\u00fcn %10&#8217;undan fazlas\u0131n\u0131 tek bir hisse senedine yat\u0131rmay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>Zarar durdurma emirleri belirleme<\/td>\n<td>Fiyat, al\u0131m fiyat\u0131ndan %7-10 d\u00fc\u015ft\u00fc\u011f\u00fcnde zarar\u0131 kesin<\/td>\n<\/tr>\n<tr>\n<td>Sermaye tahsisini a\u015famal\u0131 yapma<\/td>\n<td>Al\u0131m emirlerini birden fazla partiye b\u00f6l\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>Bilgi g\u00fcncellemeleri<\/td>\n<td>\u0130\u015f sonu\u00e7lar\u0131n\u0131 ve \u015firket bilgilerini yak\u0131ndan izleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Ayr\u0131ca, yat\u0131r\u0131mc\u0131lar Pocket Option platformundaki Zarar Durdurma, Kar Al ve teknik analiz \u00f6zellikleri gibi risk y\u00f6netim ara\u00e7lar\u0131n\u0131 kullanarak yat\u0131r\u0131m portf\u00f6ylerini zaman\u0131nda izleyip ayarlayabilirler.<\/p>\n<\/div>\n    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\"><\/span>\n        <\/a>\n    <\/div>\n    \n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>2025 Y\u0131l\u0131nda GPC Hisse Senedi Yat\u0131r\u0131m F\u0131rsatlar\u0131 \u00dczerine Sonu\u00e7<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>\u00d6zetle, Imexpharm Pharmaceutical Joint Stock Company&#8217;nin GPC hisse senedi, 2025 y\u0131l\u0131nda olumlu yat\u0131r\u0131m potansiyeli g\u00f6stermektedir. Sa\u011flam bir temel altyap\u0131, istikrarl\u0131 i\u015f b\u00fcy\u00fcmesi ve makul de\u011ferleme ile GPC, hem uzun vadeli hem de orta vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli bir se\u00e7enektir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>B\u00fcy\u00fcmeyi destekleyen fakt\u00f6rler \u015funlard\u0131r: (1) Vietnam&#8217;\u0131n ila\u00e7 sekt\u00f6r\u00fc g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme d\u00f6ng\u00fcs\u00fcnde; (2) Yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar; (3) Yeni fabrika ile art\u0131r\u0131lm\u0131\u015f \u00fcretim ve Ar-Ge kapasitesi; (4) AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layarak ihracat pazarlar\u0131n\u0131 geni\u015fletme yetene\u011fi.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Ancak, yat\u0131r\u0131mc\u0131lar\u0131n potansiyel risklere dikkat etmeleri ve uygun risk y\u00f6netim stratejileri uygulamalar\u0131 gerekmektedir. \u00d6zellikle, \u00fc\u00e7 ayl\u0131k i\u015f sonu\u00e7lar\u0131 raporlar\u0131n\u0131, yeni yat\u0131r\u0131m projeleri hakk\u0131ndaki bilgileri ve ila\u00e7 sekt\u00f6r\u00fc politikalar\u0131n\u0131 yak\u0131ndan izleyerek yat\u0131r\u0131m stratejilerine zaman\u0131nda ayarlamalar yapmalar\u0131 gerekmektedir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option uzman tahminlerine g\u00f6re, mevcut b\u00fcy\u00fcme ivmesiyle, \u00f6n\u00fcm\u00fczdeki 12 ayda GPC hisse senedi i\u00e7in makul bir fiyat hedefi, mevcut fiyattan %15-20 art\u0131\u015fla 72,000-75,000 VND&#8217;dir. Bu, yakla\u015f\u0131k %3.5&#8217;lik bir temett\u00fc ile birle\u015ftirildi\u011finde, yat\u0131r\u0131mc\u0131lar i\u00e7in %20&#8217;nin \u00fczerinde potansiyel toplam getiri sa\u011flayan \u00e7ekici bir getiridir.<\/p>\n<\/div>\n"},"faq":[{"question":"GPC hisse kodu hangi \u015firkete aittir?","answer":"GPC, 1977 y\u0131l\u0131nda kurulan Vietnam'\u0131n \u00f6nde gelen ila\u00e7 i\u015fletmelerinden biri olan Imexpharm \u0130la\u00e7 Anonim \u015eirketi'nin hisse senedi kodudur. \u015eirket, \u00f6zellikle AB-GMP ve WHO-GMP standartlar\u0131na uygun antibiyotikler ve fonksiyonel g\u0131dalar olmak \u00fczere y\u00fcksek kaliteli ila\u00e7 \u00fcr\u00fcnlerinin \u00fcretimi ve ticareti konusunda uzmanla\u015fm\u0131\u015ft\u0131r."},{"question":"Imexpharm'\u0131n Vietnam'daki di\u011fer ila\u00e7 \u015firketlerine k\u0131yasla rekabet\u00e7i avantajlar\u0131 nelerdir?","answer":"Imexpharm'\u0131n birka\u00e7 \u00f6nemli rekabet avantaj\u0131 vard\u0131r: (1) AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan az say\u0131daki Vietnaml\u0131 ila\u00e7 \u015firketlerinden biridir ve bu da AB pazar\u0131na ihracat\u0131 m\u00fcmk\u00fcn k\u0131lar; (2) Modern, y\u00fcksek teknolojiye sahip bir antibiyotik \u00fcretim tesisine sahiptir; (3) Bir\u00e7ok patentli \u00fcr\u00fcne sahip g\u00fc\u00e7l\u00fc Ar-Ge yetenekleri; (4) \u00dclke \u00e7ap\u0131nda geni\u015f bir da\u011f\u0131t\u0131m a\u011f\u0131; (5) D\u00fc\u015f\u00fck bor\u00e7 oran\u0131yla sa\u011fl\u0131kl\u0131 bir mali durum."},{"question":"GPC hissesinin 2025 y\u0131l\u0131nda olumlu beklentilere sahip olmas\u0131n\u0131n nedenleri nelerdir?","answer":"GPC hissesi olumlu de\u011ferlendirilmektedir \u00e7\u00fcnk\u00fc: (1) Vietnam'\u0131n ila\u00e7 sekt\u00f6r\u00fc %10-12'lik bir YBBO ile g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme d\u00f6ng\u00fcs\u00fcndedir; (2) Yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar yerel i\u015fletmelere avantajlar sa\u011flamaktad\u0131r; (3) Imexpharm'\u0131n i\u015f sonu\u00e7lar\u0131 istikrarl\u0131 bir b\u00fcy\u00fcme g\u00f6stermektedir; (4) Sekt\u00f6r ortalamas\u0131n\u0131n alt\u0131nda bir F\/K ile makul de\u011ferleme; (5) EVFTA sayesinde ihracat pazarlar\u0131n\u0131 geni\u015fletme potansiyeli; (6) \"Cup and Handle\" deseni ile pozitif teknik trend."},{"question":"GPC hisse senedine yat\u0131r\u0131m yaparken ba\u015fl\u0131ca riskler nelerdir?","answer":"GPC'ye yat\u0131r\u0131m yaparken ba\u015fl\u0131ca riskler \u015funlard\u0131r: (1) Yabanc\u0131 ila\u00e7 \u015firketlerinden gelen yo\u011fun rekabet; (2) \u0130thal edilen ila\u00e7 malzemelerinin fiyatlar\u0131ndaki dalgalanmalar; (3) \u0130la\u00e7 fiyat y\u00f6netimi politikalar\u0131ndaki ve ila\u00e7 ihale s\u00fcre\u00e7lerindeki de\u011fi\u015fiklikler; (4) \u0130thal malzemelere ba\u011f\u0131ml\u0131l\u0131k nedeniyle d\u00f6viz kuru riskleri; (5) Yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131n\u0131 etkileyen genel piyasa dalgalanmalar\u0131; (6) \u0130\u015f sonu\u00e7lar\u0131n\u0131n beklentileri kar\u015f\u0131lamamas\u0131."},{"question":"Bireysel yat\u0131r\u0131mc\u0131lar i\u00e7in GPC hissesi ile uygun yat\u0131r\u0131m stratejileri nelerdir?","answer":"Ama\u00e7lara ve risk i\u015ftah\u0131na ba\u011fl\u0131 olarak, yat\u0131r\u0131mc\u0131lar bu stratejileri uygulayabilir: (1) Uzun vadeli yat\u0131r\u0131m: Fiyat MA200 civar\u0131ndayken kademeli olarak biriktirin, s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme ve temett\u00fclerden faydalanmak i\u00e7in 12+ ay boyunca tutun; (2) Orta vadeli yat\u0131r\u0131m: Hisse senedi 65,000 VND direncini b\u00fcy\u00fck hacimle k\u0131rd\u0131\u011f\u0131nda sat\u0131n al\u0131n, 6-12 ay i\u00e7inde 72,000-75,000 VND hedefleyin; (3) K\u0131sa vadeli ticaret: Teknik sinyaller ve para ak\u0131\u015f\u0131 izlemeye dayal\u0131 olarak \"destekte al, diren\u00e7te sat\" stratejisini uygulay\u0131n. En \u00f6nemlisi, risk y\u00f6netimi ilkelerini uygulay\u0131n, portf\u00f6y\u00fc \u00e7e\u015fitlendirin ve tek bir hisseye portf\u00f6y\u00fcn %10'undan fazlas\u0131n\u0131 yat\u0131rmay\u0131n."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"GPC hisse kodu hangi \u015firkete aittir?","answer":"GPC, 1977 y\u0131l\u0131nda kurulan Vietnam'\u0131n \u00f6nde gelen ila\u00e7 i\u015fletmelerinden biri olan Imexpharm \u0130la\u00e7 Anonim \u015eirketi'nin hisse senedi kodudur. \u015eirket, \u00f6zellikle AB-GMP ve WHO-GMP standartlar\u0131na uygun antibiyotikler ve fonksiyonel g\u0131dalar olmak \u00fczere y\u00fcksek kaliteli ila\u00e7 \u00fcr\u00fcnlerinin \u00fcretimi ve ticareti konusunda uzmanla\u015fm\u0131\u015ft\u0131r."},{"question":"Imexpharm'\u0131n Vietnam'daki di\u011fer ila\u00e7 \u015firketlerine k\u0131yasla rekabet\u00e7i avantajlar\u0131 nelerdir?","answer":"Imexpharm'\u0131n birka\u00e7 \u00f6nemli rekabet avantaj\u0131 vard\u0131r: (1) AB-GMP standartlar\u0131n\u0131 kar\u015f\u0131layan az say\u0131daki Vietnaml\u0131 ila\u00e7 \u015firketlerinden biridir ve bu da AB pazar\u0131na ihracat\u0131 m\u00fcmk\u00fcn k\u0131lar; (2) Modern, y\u00fcksek teknolojiye sahip bir antibiyotik \u00fcretim tesisine sahiptir; (3) Bir\u00e7ok patentli \u00fcr\u00fcne sahip g\u00fc\u00e7l\u00fc Ar-Ge yetenekleri; (4) \u00dclke \u00e7ap\u0131nda geni\u015f bir da\u011f\u0131t\u0131m a\u011f\u0131; (5) D\u00fc\u015f\u00fck bor\u00e7 oran\u0131yla sa\u011fl\u0131kl\u0131 bir mali durum."},{"question":"GPC hissesinin 2025 y\u0131l\u0131nda olumlu beklentilere sahip olmas\u0131n\u0131n nedenleri nelerdir?","answer":"GPC hissesi olumlu de\u011ferlendirilmektedir \u00e7\u00fcnk\u00fc: (1) Vietnam'\u0131n ila\u00e7 sekt\u00f6r\u00fc %10-12'lik bir YBBO ile g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme d\u00f6ng\u00fcs\u00fcndedir; (2) Yerli \u00fcretilen ila\u00e7lar\u0131 \u00f6nceliklendiren politikalar yerel i\u015fletmelere avantajlar sa\u011flamaktad\u0131r; (3) Imexpharm'\u0131n i\u015f sonu\u00e7lar\u0131 istikrarl\u0131 bir b\u00fcy\u00fcme g\u00f6stermektedir; (4) Sekt\u00f6r ortalamas\u0131n\u0131n alt\u0131nda bir F\/K ile makul de\u011ferleme; (5) EVFTA sayesinde ihracat pazarlar\u0131n\u0131 geni\u015fletme potansiyeli; (6) \"Cup and Handle\" deseni ile pozitif teknik trend."},{"question":"GPC hisse senedine yat\u0131r\u0131m yaparken ba\u015fl\u0131ca riskler nelerdir?","answer":"GPC'ye yat\u0131r\u0131m yaparken ba\u015fl\u0131ca riskler \u015funlard\u0131r: (1) Yabanc\u0131 ila\u00e7 \u015firketlerinden gelen yo\u011fun rekabet; (2) \u0130thal edilen ila\u00e7 malzemelerinin fiyatlar\u0131ndaki dalgalanmalar; (3) \u0130la\u00e7 fiyat y\u00f6netimi politikalar\u0131ndaki ve ila\u00e7 ihale s\u00fcre\u00e7lerindeki de\u011fi\u015fiklikler; (4) \u0130thal malzemelere ba\u011f\u0131ml\u0131l\u0131k nedeniyle d\u00f6viz kuru riskleri; (5) Yat\u0131r\u0131mc\u0131 duyarl\u0131l\u0131\u011f\u0131n\u0131 etkileyen genel piyasa dalgalanmalar\u0131; (6) \u0130\u015f sonu\u00e7lar\u0131n\u0131n beklentileri kar\u015f\u0131lamamas\u0131."},{"question":"Bireysel yat\u0131r\u0131mc\u0131lar i\u00e7in GPC hissesi ile uygun yat\u0131r\u0131m stratejileri nelerdir?","answer":"Ama\u00e7lara ve risk i\u015ftah\u0131na ba\u011fl\u0131 olarak, yat\u0131r\u0131mc\u0131lar bu stratejileri uygulayabilir: (1) Uzun vadeli yat\u0131r\u0131m: Fiyat MA200 civar\u0131ndayken kademeli olarak biriktirin, s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme ve temett\u00fclerden faydalanmak i\u00e7in 12+ ay boyunca tutun; (2) Orta vadeli yat\u0131r\u0131m: Hisse senedi 65,000 VND direncini b\u00fcy\u00fck hacimle k\u0131rd\u0131\u011f\u0131nda sat\u0131n al\u0131n, 6-12 ay i\u00e7inde 72,000-75,000 VND hedefleyin; (3) K\u0131sa vadeli ticaret: Teknik sinyaller ve para ak\u0131\u015f\u0131 izlemeye dayal\u0131 olarak \"destekte al, diren\u00e7te sat\" stratejisini uygulay\u0131n. En \u00f6nemlisi, risk y\u00f6netimi ilkelerini uygulay\u0131n, portf\u00f6y\u00fc \u00e7e\u015fitlendirin ve tek bir hisseye portf\u00f6y\u00fcn %10'undan fazlas\u0131n\u0131 yat\u0131rmay\u0131n."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-10T19:47:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Andrew OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrew OK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\"},\"author\":{\"name\":\"Andrew OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\"},\"headline\":\"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025\",\"datePublished\":\"2025-07-10T19:47:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\"},\"wordCount\":11,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"keywords\":[\"beginner\",\"platform\",\"stock\"],\"articleSection\":[\"Markets\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\",\"name\":\"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"datePublished\":\"2025-07-10T19:47:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\",\"name\":\"Andrew OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"caption\":\"Andrew OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/andrew-ok\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/","og_locale":"tr_TR","og_type":"article","og_title":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025","og_url":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-10T19:47:44+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","type":"image\/webp"}],"author":"Andrew OK","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Andrew OK"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/"},"author":{"name":"Andrew OK","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3"},"headline":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025","datePublished":"2025-07-10T19:47:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/"},"wordCount":11,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","keywords":["beginner","platform","stock"],"articleSection":["Markets"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/","url":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/","name":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","datePublished":"2025-07-10T19:47:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/gpc-stock\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"GPC Hisse Senedi: Kapsaml\u0131 Analiz ve Yat\u0131r\u0131m F\u0131rsatlar\u0131 2025"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3","name":"Andrew OK","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","caption":"Andrew OK"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/andrew-ok\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":300355,"slug":"gpc-stock","post_title":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025","href":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/"},"pt_AA":{"locale":"pt_AA","id":300350,"slug":"gpc-stock","post_title":"A\u00e7\u00e3o GPC: An\u00e1lise Abrangente e Oportunidades de Investimento 2025","href":"https:\/\/pocketoption.com\/blog\/pt\/knowledge-base\/markets\/gpc-stock\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/300353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=300353"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/300353\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/178545"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=300353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=300353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=300353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}